Skip to main content
. 2017 Jul 19;7:5925. doi: 10.1038/s41598-017-06132-z

Figure 2.

Figure 2

Overexpression of CEP55 protein correlated with poor prognosis in patients with pancreatic cancer (PANC). (a) Western blotting detection of CEP55 protein in three adjacent normal pancreas tissues and nine pancreatic cancer tissues. (b) Immunochemical analysis of CEP55 protein expression in 126 pancreatic cancer specimens (left panel), magnification ×400. Statistical quantification of the H-score of CEP55 staining of 126 pancreatic cancer specimens (right panel). (c) Kaplan-Meier survival curves for 126 pancreatic cancer patients with high CEP55-expressing versus low CEP55-expressing tumours. (d) Multivariate analyses between CEP55 protein expression and clinicopathological characteristics of 126 pancreatic cancer specimens. *P < 0.05, **P < 0.01.